KLHDC9

Across TCGA pan-cancer cohorts, KLHDC9 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated KLHDC9 data layer compared with 28 for mass-spec protein and 1 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher KLHDC9 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated KLHDC9 expression acts as an unfavorable survival marker.

PDAC and GBM are the cancer types where KLHDC9 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	DFS	Tertile	III,IV	0.209	0.846	.024	10	view →
GBM	DFS	Quartile	All	0.220	0.468	.011	8	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

KLHDC9–PDAC (DFS)

Open the PDAC breakdown →